Overview

Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a multinational, randomized, double-blind study comparing the efficacy and safety of two single dose regimens of peramivir administered intramuscularly versus placebo in adults with uncomplicated acute influenza.
Phase:
Phase 3
Details
Lead Sponsor:
BioCryst Pharmaceuticals
Treatments:
Peramivir